I’ve refrained from getting too much into the Spitzer versus Glaxo legal shenanigans over Paxil, and whether results were withheld deliberately or not. However, suffice it to say that yet again Pharma’s PR is not exactly going to be helping the Republicans in an election year when you see editorial pieces like this from The New York Times.